Mathews S - Search Results

1

Mouse model of chronic and binge ethanol feeding (the NIAAA model).

Bertola A, Mathews S, Ki SH, Wang H, Gao B. Bertola A, et al. Among authors: mathews s. Nat Protoc. 2013 Mar;8(3):627-37. doi: 10.1038/nprot.2013.032. Epub 2013 Feb 28. Nat Protoc. 2013. PMID: 23449255 Free PMC article.

2

Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges.

Mathews S, Xu M, Wang H, Bertola A, Gao B. Mathews S, et al. Am J Physiol Gastrointest Liver Physiol. 2014 May 15;306(10):G819-23. doi: 10.1152/ajpgi.00041.2014. Epub 2014 Apr 3. Am J Physiol Gastrointest Liver Physiol. 2014. PMID: 24699333 Free PMC article. Review.

3

Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease.

Mathews S, Gao B. Mathews S, et al. Hepatology. 2013 May;57(5):2078-80. doi: 10.1002/hep.26336. Hepatology. 2013. PMID: 23609413 Free PMC article.

4

Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease.

Kong X, Feng D, Mathews S, Gao B. Kong X, et al. Among authors: mathews s. J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1(0 1):56-60. doi: 10.1111/jgh.12032. J Gastroenterol Hepatol. 2013. PMID: 23855297 Free PMC article. Review.

5

Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.

Mathews S, Feng D, Maricic I, Ju C, Kumar V, Gao B. Mathews S, et al. Cell Mol Immunol. 2016 Mar;13(2):206-16. doi: 10.1038/cmi.2015.06. Epub 2015 Feb 9. Cell Mol Immunol. 2016. PMID: 25661730 Free PMC article.

6

New drug targets for alcoholic liver disease.

Xu M, Chang B, Mathews S, Gao B. Xu M, et al. Among authors: mathews s. Hepatol Int. 2014 Sep;8 Suppl 2(Suppl 2):475-80. doi: 10.1007/s12072-014-9516-x. Epub 2014 Mar 8. Hepatol Int. 2014. PMID: 26201327 Free PMC article.

7

Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.

Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, Molle N, Mathews SA, Gao B, Kumar V. Maricic I, et al. Among authors: mathews sa. Hepatology. 2015 Apr;61(4):1357-69. doi: 10.1002/hep.27632. Epub 2015 Feb 23. Hepatology. 2015. PMID: 25477000 Free PMC article.

8

Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C.

Joshi-Barve S, Amancherla K, Patil M, Bhatnagar A, Mathews S, Gobejishvili L, Cave M, McClain C, Barve S. Joshi-Barve S, et al. Among authors: mathews s. Free Radic Biol Med. 2009 Jul 1;47(1):47-54. doi: 10.1016/j.freeradbiomed.2009.03.021. Epub 2009 Apr 1. Free Radic Biol Med. 2009. PMID: 19345260 Free PMC article.

9

Viability of Structured Gait Retraining for Improving Clinical Outcomes Following Running-related Injury in Active Duty Service Members.

Leugers K, Mathews S, Anderson R, Reilly N, Haltiwanger H, Gonnella M, Goss D. Leugers K, et al. Among authors: mathews s. Mil Med. 2024 May 21:usae218. doi: 10.1093/milmed/usae218. Online ahead of print. Mil Med. 2024. PMID: 38771705

10

Elucidating the Anticancer Mechanisms of Cinnamoyl Sulfonamide Hydroxamate: Insights From DNA Content Analysis and Gene Expression Profiling in Squamous Cell Carcinoma.

Cherian E, Goyal M, Mittal N, Mathews S, Sagir M. Cherian E, et al. Among authors: mathews s. Cureus. 2024 Mar 30;16(3):e57236. doi: 10.7759/cureus.57236. eCollection 2024 Mar. Cureus. 2024. PMID: 38686281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

612 results

Search Page